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Introduction
Sepsis is a devastating and costly disease. According to the CDC, 1.7 million US adults develop sepsis,
nearly 270,000 Americans die as a result of sepsis every year, and one in three patients who die in a
hospital have sepsis 1,2. It is a complicated process which represents the summation of varied host
immune responses in a clinical and physiological diagnosis. Although improvements in care processes,
such as the Surviving Sepsis Guidelines, have led to a significant reduction in mortality in the last 20
years3, therapeutic options are limited to variations of antibiotics and physiologic support which date
back nearly 25 years. Despite extensive research using current investigatory strategies, there is no
current mediator-directed therapy, nor a biomarker panel able to categorize disease severity or reliably
predict outcome. As such, one must ask, are these strategies capable of revealing the connection
between basic science and potential therapeutics in a system as complicated as sepsis?
By looking at other fields of study, we find a possible answer: computational/simulation models as proxy
systems. In systems engineering and other fields, these simplified systems advance understanding of
their real world counterparts by providing discrete and knowable boundary conditions. Advances in
computing power have enabled the development and testing of dynamic computational and
mathematical models of acute systemic inflammation and sepsis. While these models are currently quite
distant from direct clinical translation, they are able to provide critical insights into the dynamics of
sepsis and can serve to frame the scope and direction of both basic and clinical research. Specifically,
agent-based models (ABMs) are particularly well suited to translating basic science-derived mechanistic
knowledge into heterogeneous clinical settings4. ABMs treat a particular system as populations of
interacting components that are governed by rules for their behavior; the aggregate behavior of a
system is thus simulated by creating and running the interactions between computational objects
corresponding to those components. This can lead to emergent properties of the system not apparent
from the rules governing agent interactions. Even with simple rules, very complicated patterns and
relationships can arise. Additionally, because ABMs are defined by the rules governing each agent rather
than the aggregate behavior, they are considerably easier to implement than equation-based models,
such as those based on differential equations. Furthermore, they are adaptable to changing condition
and readily allow for incorporation of stochastic factors5. As such ABMs are well suited to representing
biological systems, where cells form a natural agent/component level for biomedical ABMs.
However, as complex objects themselves, the execution of ABMs is very computationally intensive. As
mentioned previously, aggregate behavior is not immediately apparent and ABMs are frequently
stochastic6. Consequently, ABMs require multiple simulations for sufficient validity and description of
behavior. As such there is a need to develop new analytical methods to more efficiently and effectively
extract knowledge from ABMs. One particularly computationally intensive task is the parameterization
and calibration of ABMs. This process involves adjusting the values that affect the various mechanistic
rules within the ABM and are analogous to the “weights” that govern the model’s responsiveness to
simulated perturbations.

A specific ABM which has been well described and characterized in the 20 years since it was created, the
Innate Immune Response Agent Based Model (IIRABM), remains a useful tool for research and
characterization of sepsis. The IIRABM simulates the overall dynamics of the acute inflammatory
response, producing recognizable aggregate outcomes (healing, pro-inflammatory death, hypo-immune
death, and overwhelming initial infection) that are a simplified representation of the human innate
immune system. However, its direct clinical applicability remains distant, in part due to the intensive
computing time required to characterize the model and response to interventions. It is not unique in
that the parameterization of the model is particularly intensive. In previous work7, it was shown that the
IIRABM can be characterized based on its four initializing parameters: microbial invasiveness,
toxigenesis, environmental toxicity, and patient resilience. While they have no direct clinical correlates,
they, along with the simulated outcomes, represent the parameter space of the model. Within this
space, there are regions for which simulated patients are likely to have one of the specific outcomes
listed above. These regions, termed Probabilistic Basins of Attraction (PBoAs), allow directed
investigation for specific sets of parameters of clinical interested. For example, the regions where all
simulated patients die of overwhelming infection or all heal rapidly, are not clinically relevant as they do
not represent clinically plausible behavior, whereas regions with outcome uncertainty produce diverse
model dynamics and more accurately simulate possible real world scenarios.
Within these regions, additional information can be gleaned from examining the trajectories of in silico
patients. Although the outcome of aggregate trajectories is uncertain, for individual “patients”, there
comes a point after which its outcome is certain, either death or healing. Prior to this point, the
trajectory exhibits stochastic behavior and the zone where this occurs is termed the stochastic zone. The
boundaries of this zone are clinically relevant as they represent the point of maximum injury while still
being recoverable and the point of maximum health while still progressing to death. Additionally, these
boundaries change dependent on their proximity to the PBoAs. Thus, defining these stochastic zones
allows for characterization of the model’s clinical behavior.
However, the boundaries of the stochastic region change with each parameter set and whenever
interventions, such as potential treatments, are introduced into the model. At present, there is no way
to define the boundaries of the stochastic region and thus the PBoA without running the model
throughout the entire parameter space. This represents millions of simulated runs and significant
computing time. Any increase in efficiency in predicting the boundaries of the stochastic zone based on
location in parameter space would represent a significant decrease in time required to assess the model.
This process of predicting boundaries based on a starting set of values is essentially a task of regression.
In its most basic sense, regression involves fitting inputs to outputs based on a rule or set of rules. The
simplest form is linear regression where these inputs and outputs are related by a linear function f(x) =
ax+b, choosing the parameters a and b to minimize some measure of error between true outputs and
predicted outputs. Linear regression, while extremely useful, is inadequate for all but the simplest
relationships between inputs and outputs. The basic function can be augmented by including polynomial
terms, but these still do not fill the needs of sufficiently large or difficult parameter regression as they
are still limited by only one layer of inter-relatability. To identify deep patterns in simulation data,
machine learning methods become necessary tools for regression. Artificial neural networks, a type of
machine learning, introduce multiple layers of modeling and weights within each layer. In a basic single
layer ANN, we can define a function to produce output 𝑜1 from inputs 𝑖1 , 𝑖2 as f(i1 , i2 ) =
a(w11 i1 + w12 i2 ) where w11 , w12 are weights that adjust the impact of i1 , i2 respectively and a(x) is

an activation function allowing for nonlinearity necessary for binary classification or logistic regression.
This basic ANN, excluding the a(x) function is essentially a multilinear regression model as it combines
two linear regression models to produce a single output. At this point, however, it still is not sufficient
for characterizing more complicated problems. The next step, therefore, is to add more complexity. If
we call our initial function 𝑙1 we can imagine adding similar functions with the same inputs, but with
different weights and activation functions, which themselves become the inputs of another function,
which then can predict the desired output. For example, we can define:
𝑙1 = a1 (w11 i1 + w12 i2 ), l2 = a2 (w21 i1 + w22 i2 ), 𝑙3 = a3 (w31 i1 + w32 i2 )
Related by a final equation 𝑝 = 𝑏1 (𝑣1 𝑙1 + 𝑣2 𝑙2 + 𝑣3 𝑙3 ). The weights of these equations can be
sequentially adjusted to produce the lowest measure of error between the output of 𝑝 and the actual
output 𝑜1 . Furthermore, the model can be made arbitrarily complex by introducing more layers and
functions within each layer. This process is what makes neural networks so well suited to identifying
patterns in vast amounts of data. They have been employed successfully to predict outcomes in multiple
biologic systems8,9.
In our project we applied an Artificial Neural Network to a previously generated comprehensive data set
from the IIRABM, and successively reduced the amount of training data while attempting to maintain
the ability of the ANN to accurately predict clinically relevant tipping points given a particular parameter
set.
Methods
The PBoA data set was obtained from IIRABM parameter sweep data which explored 40 injury sizes and
800 parameter combinations, each with 100 stochastic replicates. PBoA boundaries were calculated by
determining the greatest oxygen deficit an in silico simulation could reach and still heal and the lowest
oxygen deficit an in silico patient could reach and still die for each parameter combination. Up to 90% of
the data was used for training, as discussed in the results, and 10% for testing/validation. In order to
regress the PBoA boundaries, we utilized a fully connected deep network which takes a 4-dimensional
parameter vector as input, feeding into two fully connected layers with 256 and 128 nodes respectively,
separated by a dropout layer 10 with a 20% dropout ration, and finally to a single output node. The loss
metric used to train this algorithm is the Mean-Squared-Error (MSE). Prediction variance and error bars
were calculated through stochastic variations to the dropout layer, as demonstrated with regards to
Active Learning for regression in 11

Results and Discussion:
Figure 1 shows the accuracy of the ANN in predicting the boundaries of the stochastic zone versus
percent training set withheld. A maximal accuracy of 96% (SD 0.0026) is, predictably, obtained when
evaluating the largest portion of the dataset at 90%. However, the model can predict within an
acceptable degree of accuracy with inclusion of 20% of the training set (accuracy 87.30%, SD 0.570).
Note that this accuracy is calculated as an internal metric of the KERAS structure in which the ANN is
built.
These tipping points define the boundaries of stochastic behavior of the IIRABM for a given parameter
set. They represent the most harm a simulated patient can incur while then going on to fully heal or the

healthiest a simulated patient can be while the proceeding to die. If a simulated trajectory crosses these
tipping points, it fate becomes definite; they are the boundaries of the life and death attractors for a
specific parameter set. Prior to crossing the tipping points, the behavior is stochastic. This was shown in
previous work by halting and re-seeding the trajectory7. As a trajectory approached the boundary, a
greater percentage of re-seeded trajectories converged on the respective fate, but some, still would
diverge to the opposite fate.
To reiterate, this behavior is only observed in certain regions of the IIRABM’s parameter space for which
the model’s behavior is unknown. For any parameter set, the trajectory will be mapped to either the
healthy attractor or the death attractor. For specific parameters in this region of parameter space, the
behavior is unpredictable. These Probablistic Basins of Attraction characterize the IIRABM’s behavior
and examination of their boundaries may provide insight to future targets for interventions and
therapeutics. However, the degree of unpredictability changes as we move through parameter space.
Certain combinations of parameters will be more likely to result in simulated death than health, but still
exhibit stochastic behavior; in other words, the boundaries of the stochastic zone are different for each
parameter set. Thus, characterizing the stochastic boundaries defines the PBoAs which themselves
define the model’s behavior.
However, our present work identifies these tipping points with complete knowledge of the solution. As
such, we are not predicting the boundaries for the stochastic zone, but confirming whether they can be
predicted with limited information. As such, this project answers the question, is it possible to predict
the boundaries with limited information of parameter space? Although it is useful as a concept, other
methods to confirm the ANN’s effectiveness at predicting the boundaries are necessary when this is put
into practice with novel simulations of the IIRABM. We must define a metric that can determine
whether the NN is fully trained on a data set which is not representative of the entire IIRABM parameter
space.
The NN’s effectiveness is determined by how well it “fits” the data. For any neural network, there is a
fine line between overfitting and underfitting to the data available. In underfitting, the NN is not given
enough data to be able to predict the outcome. This can happen when the NN has not had enough
repetitions to connect the data properly or if the NN does not have enough complexity to deal with the
connections in the data. In the case of insufficient complexity, we can say the NN has high bias,
essentially the model is too rigid in structure to adapt to the data. A simple example of this would be
attempting to fit a linear model to a polynomial function. In overfitting, the NN has seen too much data
and is no longer generalizable to other data. Essentially, the NN becomes fitted to the noise in the
dataset, termed having high variance. In either of these circumstances, the NN is not able to predict
outcomes with any degree of confidence. As such It is necessary determine when a NN is properly fit
and trained on the data and able to make accurate predictions.
There is no exact measure of fitment. However, it can be graphically represented and evaluated using
validation curves examples of which are shown in figure 2. These plots model error against iterations in
both the training set, and a withheld validation set. As the model is trained, the error or loss in both the
training set and testing set should decrease over time and eventually flatten. One can evaluate fitment
by examining how or if these error decrease. In the case of a model with high bias, which underfits the
data, the validation and training curves will fail to converge as seen in fig 2D. If the NN is underfit due to
insufficient training data as opposed to high bias, the amount of loss will be seen decreasing throughout

the training as opposed to flattening. Alternatively, if the NN has high variance and overfits, the training
and validation curves will initially converge, but the validation loss will then start to increase as seen in
fig 2B.
Putting these concepts together, we envision a neural net augmented workflow as follows: simulations
run on the IIRABM with novel interventions introduced at some time point, following intervention,
batches of 500 parameter sets are simulated to completion, stochastic trajectory analysis is perform3ed
nd passed through a neural net, a validation curve is generated based on these parameter and examined
for fitment. If the neural network displays underfitting, then more of the parameter space is explored
and simulated until the neural network is properly fit. At this point, we can definitively the boundaries of
the stochastic zone are defined, thus allowing us to characterize the PBoAs and so the IIRABM following
a supposed intervention.
To rephrase our premise, we start with complete knowledge of data for the entire population, our
parameter space, and determined that sampling 20% of our population allows for the population data as
a whole to be characterized with 90% accuracy. In other words, we determined the necessary n for
which valid assumptions of the population can be made. Just as with its biologic correlate, this
represents a significant increase in efficiency in output of the IIRABM. Although the neural network is
computationally intensive, it is 100 times cheaper to re-train the neural network than to run a single
simulation of one parameter set on the IIRABM, which requires 10 hours of CPU time. Thus, our present
work represents an opportunity for a monumental increase in possible output and discovery possible
with the IIRABM.

Figures

Figure 2 displays accuracy of the ANN in predicting boundaries of the
stochastic zone based on percentage of total data used in the training
set. Error bars are standard deviation.

Figure 3 A-D. Examples of neural net validation curves plotting loss vs number of epochs. Training loss is
shown in blue, validation set loss is shown in orange. All curves are a result of neural nets trained on the
same data. 2A is an example of a well fit curve. the neural net here uses 4 layers of 256, 128, 128, and
64 nodes. note that both validation and training loss decrease significantly and converge as epochs
progress indicating sufficient complexity of neural net. 2B demonstrates overfitting of a less
complicated neural net with 2 layers of 16 and 4 nodes. Note that while the validation set and training
set loss initially decrease, they begin to diverge after 400 epochs indicating overtraining, or high
variance. 2C uses the same neural net as 2B, but training is ended after 50 epochs to show underfitting.
Both validation set and training set loss are still decreasing before training has finished. 2D
demonstrates underfitting due to high bias. the neural net consists of 1 layer with 1 node and is too
rigid to predict the behavior of the model despite training to 2000 epochs.
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